Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response

Wael A. Aljaroudi, M. C. Alraies, Manuel D. Cerquiera, Wael A. Jaber

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response'. Together they form a unique fingerprint.

Medicine & Life Sciences